Results for tag: "Entacapone"

Entacapone is a drug used to treat Parkinson's disease, a neurological disorder that affects movement. It is a catechol-O-methyltransferase (COMT) inhibitor, which works by blocking the breakdown of dopamine in the brain. This helps to improve the symptoms of Parkinson's, such as tremors, stiffness, and difficulty walking. Entacapone is part of a class of drugs known as Central Nervous System (CNS) drugs, which are used to treat a variety of neurological disorders. Entacapone is typically used in combination with other drugs, such as levodopa, to treat Parkinson's disease. It is available in tablet form and is taken orally. It is generally well-tolerated, with the most common side effects being nausea, vomiting, and diarrhea. The entacapone market is a small but growing segment of the CNS drugs market. It is used to treat a wide range of neurological disorders, including Parkinson's disease, and is becoming increasingly popular due to its effectiveness and safety profile. Some companies in the entacapone market include Merck & Co., Inc., Novartis AG, and Teva Pharmaceutical Industries Ltd. Show Less Read more